Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.083 | 0.06 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.06 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.085 | 0.06 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.07 |